Potential value of vitamin E in cancer patients with venous access devices

Cynthia C Chernecky, Denise Macklin, Katherine Nugent, Jennifer L Waller

Research output: Contribution to journalArticle

Abstract

Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs. Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer. Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD). Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD. Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.

Original languageEnglish (US)
Pages (from-to)71-73
Number of pages3
JournalJAVA - Journal of the Association for Vascular Access
Volume13
Issue number2
DOIs
StatePublished - Jan 1 2008
Externally publishedYes

Fingerprint

Vitamin E
Equipment and Supplies
Neoplasms
Therapeutic Uses
Focus Groups
Endotoxins
Capsules

ASJC Scopus subject areas

  • Medicine (miscellaneous)

Cite this

Potential value of vitamin E in cancer patients with venous access devices. / Chernecky, Cynthia C; Macklin, Denise; Nugent, Katherine; Waller, Jennifer L.

In: JAVA - Journal of the Association for Vascular Access, Vol. 13, No. 2, 01.01.2008, p. 71-73.

Research output: Contribution to journalArticle

@article{17e8aa406b2f4e8cbcbd407086cd4d44,
title = "Potential value of vitamin E in cancer patients with venous access devices",
abstract = "Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs. Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer. Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD). Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD. Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.",
author = "Chernecky, {Cynthia C} and Denise Macklin and Katherine Nugent and Waller, {Jennifer L}",
year = "2008",
month = "1",
day = "1",
doi = "10.2309/java.13-2-4",
language = "English (US)",
volume = "13",
pages = "71--73",
journal = "JAVA - Journal of the Association for Vascular Access",
issn = "1552-8855",
publisher = "Association for Vascular Access",
number = "2",

}

TY - JOUR

T1 - Potential value of vitamin E in cancer patients with venous access devices

AU - Chernecky, Cynthia C

AU - Macklin, Denise

AU - Nugent, Katherine

AU - Waller, Jennifer L

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs. Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer. Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD). Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD. Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.

AB - Background: Vitamin E has antiplatelet, fibrinolytic and endotoxin properties that may help avoid the problems of occlusion or inability to withdraw blood from port VADs. Purpose: Disseminate information about the non-traditional therapeutic use of vitamin E associated with care of Venous Access Devices (VAD) in patients with cancer. Methodology: In-person focus groups. Sample of 22 cancer patients who had port Venous Access Devices (VAD). Findings: Fourteen percent (N = 3) of patients felt that taking vitamin E, 400 -800 IU per day orally, in capsule form, avoided the problems of occlusion or inability to withdraw blood from their current VAD. Practice Implications: The effects of vitamin E on occlusion and inability to withdraw blood in caring for patients who have port VADs, requires further investigation.

UR - http://www.scopus.com/inward/record.url?scp=47549093192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47549093192&partnerID=8YFLogxK

U2 - 10.2309/java.13-2-4

DO - 10.2309/java.13-2-4

M3 - Article

AN - SCOPUS:47549093192

VL - 13

SP - 71

EP - 73

JO - JAVA - Journal of the Association for Vascular Access

JF - JAVA - Journal of the Association for Vascular Access

SN - 1552-8855

IS - 2

ER -